Comparative study on the induction of cytostasis and apoptosis by ICI 182,780 and tamoxifen in an estrogen receptor-negative ovarian cancer cell line

International Journal of Cancer

Volumn 76, Issue 1, 1998, Pages 47-54

  Ercoli, Alfredo ^a   Scambia, Giovanni ^a   Fattorossi, Andrea ^a   Raspaglio, Giuseppina ^a   Battaglia, Alessandra ^a   Cicchillitti, Lucia ^a   Malorni, Walter ^b   Rainaldi, Gabriella ^b   Panici, Pierluigi Benedetti ^a   Mancuso, Salvatore ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; FULVESTRANT; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL ADHESION; CELL DIVISION; CELL KINETICS; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL NUCLEUS; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; OVARIAN NEOPLASMS; RECEPTORS, ESTROGEN; TAMOXIFEN; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0031970632     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980330)76:1<47::AID-IJC9>3.0.CO;2-Y     Document Type: Article

References (26)

1. BORTNER, C.D., OLDENBURG, N.B.E, and CIDLOWSKI, J.A., The role of DNA fragmentation in apoptosis. Trends Cell Biol., 5, 21-25 (1995).
2. BUCKLEY, M.T. and GOA, K.L., Tamoxifen, a reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. Drugs, 37, 451-490 (1989).
3. COHEN, M.G., SUN, X.M., SNOWDEN, R.T., DINSDALE, D. and SKILLETER, D.M., Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J., 286, 331-334 (1992).
4. DEFRIEND, D.J., HOWELL, A., NICHOLSON, R.I., ANDERSON, E., DOWSETT, M., MANSEL, R.E., BLAMEY, R.W., BUNDREIX N.J., ROBERTSON, J.F. and SUNDERS, C., Investigation of a new pure antiestrogen (ICI 182,780) in women with primary breast cancer. Cancer Res., 54, 408-414 (1994).
5. DESJARDINS, L.M. and MACMANUS, J.P., An adherent cell model to study different stages of apoptosis. Exp. Cell Res., 216, 380-387 (1995).
6. DE VINCENZO, R., SCAMBIA, G., BENEDETTI PANICI, P., FATTOROSSI, A., BONANNO, G., FERLINI, C., ISOLA, G., PERNISCO, S. and MANCUSO, S., Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells. Int. J. Cancer, 68, 340-348 (1996).
7. ELIOPOULOS, A.G., KERR, D.J., HEROD, J., HODGKINS, L., KRAJEWSKI, S., REED, J.C. and YOUNG, U.S., The control of apoptosis and drug resistence in ovarian cancer: influence of p53 and Bcl-2. Oncogene, 11, 1217-1228 (1995).
8. FATTOROSSI, A., PIERELLI, L., SCAMBIA, G., CIARLI, M. BONANNO, G., BATTAGLIA, A., BENEDETTI PANICI, P., BIZZI, B. and MANCUSO, S., A multiparunieter flow cytometric approach to hemopoietic differentiation in vitro. Cytometry (Suppl. 8), 79 (1996).
9. FILIPSKI, J., LEBLANC, J., YOHDALE, T., SIKORSKA, M. and WALKER, P.R., Periodicity of DNA folding in higher order chroination structures. EMBO J., 9, 1319-1327 (1990).
10. HOWELL, A., DEFRIEND, D.J., ROBERTSON, J.F., BLAMEY, R.W., ANDERSON, L., ANDERSON, E., STCLIFFE, F.A. and WALTON, P., Pharmacokinetics, pharmacological and anti-tumor effects of the specific anti-oestrogen ICI 182,780 in women with advanced breast cancer. Brit. J. Cancer, 74, 300-308 (1996).
11. IWASAKI, K., TOMS, S.A., BARNETT, G.H., ESTES, M.L., GUPTA, M.K. and BARNA, B.P., Inhibitory effects of tamoxifen and tumor necrosis factor alpha on human glioblastoma cells. Cancer Immunol. Immunother., 40, 228-234 (1995).
12. JAIYESIMI, I.A., BUZDAR, A.U., DECKER, D.A. and HORTOBAGYI, G.N., Use of tamoxifen for breast cancer: twenty-eight years later. J. clin. Oncol., 13, 513-529 (1995).
13. KANG, Y., CORTINA, R. and PERRY, R.R., Role of c-myc in tamoxifen-induced apoptosis in estrogen-independent breast cancer cells. J. nat. Cancer Inst., 88, 279-284 (1996).
14. KO, L.J. and PRIVES, C., p53: puzzle and paradigm. Genes Dev., 10, 1054-1072 (1996).
15. LYONS, A.B. and CHRISTOPHER, R.P., Determination of lymphocyte division by flow cytometry. J. immunol. Methods, 171, 131-137 (1994).
16. MARKMAN, M., ISEMINGER, K.A., HATCH, K.D., CREASMAN, W.T., BARNES, W. and DUBESHTER, B., Tamoxifen in platinum-refractory ovarian cancer: a Gynecologic Oncology Group ancillary report. Gynecol. Oncol., 62, 4-6 (1996).
17. MARTINS, L.M. and EARNSHAW, W.C., Apoptosis: alive and kicking in 1997. Trends Cell Biol., 7, 111-114 (1997).
18. OBERHAMMER, F., WILSON, J.W., DIVE, C., MORRIS, D.I., HICKMAN, J.A., WAKELING, A.E., WALKER, P.R. and SIKORSKA, M., Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior or in the absence of internucleosomal fragmentation. EMBO J., 12, 3679-3684 (1993).
19. RUOSLAHTI, E. and REED, J.C., Anchorage dependence, integrins, and apoptosis. Cell, 77, 477-478 (1994).
20. SAMBROOK, J., FRITSCH, E.S. and MANIATIS, T., Molecular cloning (2nd ed.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989).
21. TRUMP, D.L., SMITH, D.C., ELLIS, P.G., ROGERS, M.P., SCHOLD, C.S., WINER, E.P., PANELLA, T.J., JORDAN, V.C. and FINE, R.L., High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase-1 trial in combination with vinblastine. J. nat. Cancer Inst., 84, 1811-1816 (1992).
22. WAKELING, A.E., The future of new pure antiestrogens in clinical breast cancer. Breast Cancer Res. Treat., 25, 1-9 (1993).
23. WAKELING, A.E. and BOWLER, J., Biology and mode of action of pure antioestrogens. J. Steroid. Biochem., 30, 141-147 (1988).
24. WAKELING, A.E., DUKES, M. and BOWLER, J., A potent specific pure antiestrogen with clinical potential. Cancer Res., 51, 3867-3873 (1991).
25. WALKER, P.R., SMITH, C., YOUDALE, T., LEBLANC, J., WHITFIELD, J.F. and SIKORSKA, M., Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res., 51, 1078-1085 (1991).
26. WILSON, J.W., WAKELING, A.E., MORRIS, I.D., HICKMAN, J.A. and DIVE, C., MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage. Int. J. Cancer, 61, 502-508 (1995).